"Neoplasm Staging" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
Descriptor ID |
D009367
|
MeSH Number(s) |
E01.789.625
|
Concept/Terms |
Neoplasm Staging- Neoplasm Staging
- Staging, Neoplasm
- Tumor Staging
- Staging, Tumor
- Cancer Staging
- Staging, Cancer
TNM Staging- TNM Staging
- Staging, TNM
- TNM Staging System
- Staging System, TNM
- Staging Systems, TNM
- System, TNM Staging
- Systems, TNM Staging
- TNM Staging Systems
- TNM Classification
- Classification, TNM
- Classifications, TNM
- TNM Classifications
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Staging".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Staging".
This graph shows the total number of publications written about "Neoplasm Staging" by people in this website by year, and whether "Neoplasm Staging" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 7 | 7 |
1996 | 0 | 7 | 7 |
1997 | 0 | 10 | 10 |
1998 | 0 | 12 | 12 |
1999 | 0 | 9 | 9 |
2000 | 2 | 9 | 11 |
2001 | 2 | 15 | 17 |
2002 | 2 | 11 | 13 |
2003 | 1 | 32 | 33 |
2004 | 1 | 20 | 21 |
2005 | 2 | 28 | 30 |
2006 | 1 | 25 | 26 |
2007 | 1 | 33 | 34 |
2008 | 2 | 45 | 47 |
2009 | 2 | 36 | 38 |
2010 | 0 | 42 | 42 |
2011 | 2 | 48 | 50 |
2012 | 2 | 43 | 45 |
2013 | 3 | 43 | 46 |
2014 | 2 | 40 | 42 |
2015 | 2 | 54 | 56 |
2016 | 4 | 42 | 46 |
2017 | 5 | 56 | 61 |
2018 | 1 | 38 | 39 |
2019 | 5 | 49 | 54 |
2020 | 3 | 37 | 40 |
2021 | 3 | 30 | 33 |
2022 | 0 | 18 | 18 |
2023 | 2 | 13 | 15 |
2024 | 7 | 10 | 17 |
2025 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Staging" by people in Profiles.
-
Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Patients with Cervical Cancer Undergoing Definitive Chemoradiation. Clin Cancer Res. 2025 Feb 17; 31(4):697-706.
-
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer. Clin Cancer Res. 2025 Feb 03; 31(3):529-542.
-
Polygenic Score for Clinicopathologic Features and Survival Outcomes in Papillary Thyroid Carcinoma. JAMA Otolaryngol Head Neck Surg. 2025 Feb 01; 151(2):113-120.
-
Lymph Node Staging and Treatment in Pediatric Patients With Soft Tissue Sarcomas: A Consensus Opinion From the Children's Oncology Group, European paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe. Pediatr Blood Cancer. 2025 Apr; 72(4):e31538.
-
Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma. Clin Cancer Res. 2025 Jan 17; 31(2):258-265.
-
Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma. Blood. 2025 Jan 16; 145(3):290-299.
-
Treatment of focal anaplastic Wilms tumor: A report from the Children's Oncology Group AREN0321 and AREN03B2 studies. Cancer. 2025 Jan 15; 131(2):e35713.
-
The Society of Thoracic Surgeons (STS) Clinical Practice Guideline on Surgical Management of Oligometastatic Non-small Cell Lung Cancer. Ann Thorac Surg. 2025 Mar; 119(3):495-508.
-
Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB-D melanoma: a phase 1/2 trial. Nat Med. 2025 Jan; 31(1):144-151.
-
Occult metastases and survival of lung cancer by clinical diagnosis and CT screening: A simulation study. PLoS One. 2025; 20(1):e0313544.